AAAAAA

   
Results: 1-23 |
Results: 23
MYONECROSIS AFTER REVASCULARIZATION PROCEDURES
Authors: CALIFF RM ABDELMEGUID AE KUNTZ RE POPMA JJ DAVIDSON CJ COHEN EA KLEIMAN NS MAHAFFEY KW TOPOL EJ PEPINE CJ LIPICKY RJ GRANGER CB HARRINGTON RA TARDIFF BE CRENSHAW BS BAUMAN RP ZUCKERMAN BD CHAITMAN BR BITTL JA OHMAN EM
Citation: Rm. Califf et al., MYONECROSIS AFTER REVASCULARIZATION PROCEDURES, Journal of the American College of Cardiology, 31(2), 1998, pp. 241-251
METABOLISM OF BENZOCAINE DURING PERCUTANEOUS-ABSORPTION IN THE HAIRLESS GUINEA-PIG - ACETYLBENZOCAINE FORMATION AND ACTIVITY
Authors: KRAELING MEK LIPICKY RJ BRONAUGH RL
Citation: Mek. Kraeling et al., METABOLISM OF BENZOCAINE DURING PERCUTANEOUS-ABSORPTION IN THE HAIRLESS GUINEA-PIG - ACETYLBENZOCAINE FORMATION AND ACTIVITY, Skin pharmacology, 9(3), 1996, pp. 221-230
PANEL DISCUSSION NUMBER-1
Authors: MYERS MG MEREDITH PA STEWART WH LIPICKY RJ ELLIOTT HL WHITE WB FELDMAN R CARRUTHERS SG
Citation: Mg. Myers et al., PANEL DISCUSSION NUMBER-1, American journal of hypertension, 9(10), 1996, pp. 87-90
ON THE TROUGH-TO-PEAK RATIO OF DRUG EFFECT IN ANTIHYPERTENSIVE TRIALS
Authors: FENICHEL RR LIPICKY RJ
Citation: Rr. Fenichel et Rj. Lipicky, ON THE TROUGH-TO-PEAK RATIO OF DRUG EFFECT IN ANTIHYPERTENSIVE TRIALS, American journal of hypertension, 9(10), 1996, pp. 105-107
PANEL DISCUSSION NUMBER-2
Authors: MYERS MG LIPICKY RJ USCINOWICZ T CARRUTHERS SG WHITE WB
Citation: Mg. Myers et al., PANEL DISCUSSION NUMBER-2, American journal of hypertension, 9(10), 1996, pp. 108-109
COMBINATION PRODUCTS AS FIRST-LINE PHARMACOTHERAPY
Authors: FENICHEL RR LIPICKY RJ
Citation: Rr. Fenichel et Rj. Lipicky, COMBINATION PRODUCTS AS FIRST-LINE PHARMACOTHERAPY, Archives of internal medicine, 155(1), 1995, pp. 117-117
SHORT AND LONG-ACTING ORAL NITRATES FOR STABLE ANGINA-PECTORIS
Authors: THADANI U LIPICKY RJ
Citation: U. Thadani et Rj. Lipicky, SHORT AND LONG-ACTING ORAL NITRATES FOR STABLE ANGINA-PECTORIS, Cardiovascular drugs and therapy, 8(4), 1994, pp. 611-623
OINTMENTS AND TRANSDERMAL NITROGLYCERIN PATCHES FOR STABLE ANGINA-PECTORIS
Authors: THADANI U LIPICKY RJ
Citation: U. Thadani et Rj. Lipicky, OINTMENTS AND TRANSDERMAL NITROGLYCERIN PATCHES FOR STABLE ANGINA-PECTORIS, Cardiovascular drugs and therapy, 8(4), 1994, pp. 625-633
TROUGH-PEAK RATIO - THE RATIONALE BEHIND THE UNITED-STATES FOOD-AND-DRUG-ADMINISTRATION RECOMMENDATIONS
Authors: LIPICKY RJ
Citation: Rj. Lipicky, TROUGH-PEAK RATIO - THE RATIONALE BEHIND THE UNITED-STATES FOOD-AND-DRUG-ADMINISTRATION RECOMMENDATIONS, Journal of hypertension, 12, 1994, pp. 17-19
METHODOLOGICAL ASPECTS OF THE TROUGH-PEAK MEASUREMENT - DISCUSSION
Authors: HANSSON L VANZWIETEN PA MYERS MG REID JL RODICIO JL MENARD J LIPICKY RJ SALVETTI A PICKERING TG
Citation: L. Hansson et al., METHODOLOGICAL ASPECTS OF THE TROUGH-PEAK MEASUREMENT - DISCUSSION, Journal of hypertension, 12, 1994, pp. 27-28
COMBINATION PRODUCTS AS FIRST-LINE PHARMACOTHERAPY
Authors: FENICHEL RR LIPICKY RJ
Citation: Rr. Fenichel et Rj. Lipicky, COMBINATION PRODUCTS AS FIRST-LINE PHARMACOTHERAPY, Archives of internal medicine, 154(13), 1994, pp. 1429-1430
ROLE OF SURROGATE END-POINTS IN THE EVALUATION OF DRUGS FOR HEART-FAILURE
Authors: LIPICKY RJ PACKER M
Citation: Rj. Lipicky et M. Packer, ROLE OF SURROGATE END-POINTS IN THE EVALUATION OF DRUGS FOR HEART-FAILURE, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000179-10000184
MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .4. ASSESSMENT OF CLINICAL OUTCOME IN HEART-FAILURE - DISCUSSION-IX
Authors: PITT B ELKAYAM U GUYATT GH LIPICKY RJ PACKER M YUSUF S
Citation: B. Pitt et al., MECHANISMS AND MANAGEMENT OF HEART-FAILURE - IMPLICATIONS OF CLINICAL-TRIALS FOR CLINICAL-PRACTICE - PROCEEDINGS OF A SYMPOSIUM SPONSORED BY THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE .4. ASSESSMENT OF CLINICAL OUTCOME IN HEART-FAILURE - DISCUSSION-IX, Journal of the American College of Cardiology, 22(4), 1993, pp. 10000192-10000193
TESTING FOR THE EXISTENCE OF A DESIRABLE DOSE COMBINATION
Authors: HUNG HMJ CHI GYH LIPICKY RJ
Citation: Hmj. Hung et al., TESTING FOR THE EXISTENCE OF A DESIRABLE DOSE COMBINATION, Biometrics, 49(1), 1993, pp. 85-94
MEASURING QT INTERVALS
Authors: WENGER T CAMM J MOSS A LIPICKY RJ
Citation: T. Wenger et al., MEASURING QT INTERVALS, The American journal of cardiology, 72(6), 1993, pp. 20000033-20000034
CORRECTING THE QT MEASUREMENT
Authors: WENGER T MOSS A JAILLON P WOOSLEY R LIPICKY RJ MORGANROTH J
Citation: T. Wenger et al., CORRECTING THE QT MEASUREMENT, The American journal of cardiology, 72(6), 1993, pp. 20000034-20000035
SCREENING FOR SAFETY
Authors: FRIDAY K LIPICKY RJ WOOSLEY R
Citation: K. Friday et al., SCREENING FOR SAFETY, The American journal of cardiology, 72(6), 1993, pp. 20000035-20000035
A VIEWPOINT ON DRUGS THAT PROLONG THE QT(C) INTERVAL
Authors: LIPICKY RJ
Citation: Rj. Lipicky, A VIEWPOINT ON DRUGS THAT PROLONG THE QT(C) INTERVAL, The American journal of cardiology, 72(6), 1993, pp. 20000053-20000054
CAN WE PROLONG REPOLARIZATION WITHOUT TORSADES
Authors: ESCANDE D LIPICKY RJ MOSS A RODEN D MOORE EN
Citation: D. Escande et al., CAN WE PROLONG REPOLARIZATION WITHOUT TORSADES, The American journal of cardiology, 72(6), 1993, pp. 20000056-20000057
POSTMARKETING SURVEYS
Authors: JAILLON P LIPICKY RJ BOTSTEIN P MOSS A
Citation: P. Jaillon et al., POSTMARKETING SURVEYS, The American journal of cardiology, 72(6), 1993, pp. 20000057-20000058
CARDIOACTIVE EFFECTS OF NONCARDIAC DRUGS
Authors: SEDMAN A MOORE EN LIPICKY RJ RODEN D
Citation: A. Sedman et al., CARDIOACTIVE EFFECTS OF NONCARDIAC DRUGS, The American journal of cardiology, 72(6), 1993, pp. 20000057-20000057
QT INTERVAL AND TORSADES
Authors: LIPICKY RJ MORGANROTH J GOLDBERG M
Citation: Rj. Lipicky et al., QT INTERVAL AND TORSADES, The American journal of cardiology, 72(6), 1993, pp. 20000058-20000058
RELATION BETWEEN DOSE AND QT INTERVAL
Authors: BUTROUS G LIPICKY RJ MOORE EN
Citation: G. Butrous et al., RELATION BETWEEN DOSE AND QT INTERVAL, The American journal of cardiology, 72(6), 1993, pp. 20000059-20000059
Risultati: 1-23 |